ORF08 - Rare and Complex Bone Diseases

ORF Chair-Primary(s)

• 

  Muriel Babey, MD (she/her/hers)

  Assistant Professor of Medicine
  Stanford University, Division of Endocrinology, Gerontoloy and Metabolism
  Kensington, CA, United States

  Disclosure(s): No financial relationships to disclose

Presentations:

• 9:45 AM - 9:50 AM CT

  Clinical and Genetic Evaluation of Osteogenesis Imperfecta with Variable Expressivity
  

  Rapid and Poster Presenter: Livia Marcela Santos, PhD (she/her/hers) – FAC CIENCIAS MEDICAL STA CASA SP

  Senior Author/Primary Investigator: Livia Marcela Santos, PhD (she/her/hers) – FAC CIENCIAS MEDICAL STA CASA SP

  Co-Author: Graziella Luciano Antonio, Doctor – Santa Casa de São Paulo

  Co-Author: Jessika Medeiros de Barros Lima, Doctor – Santa Casa de São Paulo

  Co-Author: Manuela Giuliana Marcondes Rocha Braz, PhD – Santa Casa de São Paulo

  Co-Author: Caroline Olivati, PhD – Fleury

  Co-Author: Nilza Maria Scalissi, PhD – FAC CIENCIAS MEDICAL STA CASA SP

  Co-Author: JOSE VIANA LIMA JUNIOR, n/a – Santa Casa de Sao Paulo
• 9:50 AM - 9:55 AM CT

  Inhibition of Activin A Stops the Regrowth of Surgically Resected Heterotopic Bone in a Mouse Model of Fibrodysplasia Ossificans Progressiva
  

  Co-Author: Lily Huang, n/a – Regeneron Pharmaceuticals, Inc.

  Co-Author: Lili Wang, n/a (she/her/hers) – Regeneron Pharmaceuticals, Inc.

  Co-Author: nanditha Das, n/a (she/her/hers) – Regeneron Pharmaceuticals, Inc.

  Rapid and Poster Presenter: Aris Nikolaos Economides, Ph.D. (he/him/his) – Regeneron Pharmaceuticals, Inc.
• 9:55 AM - 10:00 AM CT

  Severe Hypocalcemia from Zoledronic Acid Administration in Adult with Multicentric Carpotarsal Osteolysis Syndrome and Recurrent Fractures
  

  Rapid and Poster Presenter: Polly Fu Teng, MD (she/her/hers) – UNIVERSITY OF CALIFORNIA - DAVIS

  Senior Author/Primary Investigator: Polly Fu Teng, MD (she/her/hers) – UNIVERSITY OF CALIFORNIA - DAVIS

  Co-Author: Neil S. Evans, MD – University of California Davis

  Co-Author: Brian Y. Young, MD/PhD – UCLA DEPT OF MEDICINE
• 10:00 AM - 10:15 AM CT

  Safety and Efficacy of Garetosmab in Adults with Fibrodysplasia Ossificans Progressiva: Week 56 Results from the Phase 3 OPTIMA Study
  

  Co-Author: Riccardo Papa, MD – IRCCS Istituto Giannina Gaslini

  Co-Author: Susan Rhee, MD – Regeneron Pharmaceuticals, Inc.

  Co-Author: Patricia Delai, MD – Hospital Israelita Albert Einstein, Instituto de Ensino e Pesquisa

  Co-Author: Keqin Zhang, n/a – Tongji Hospital, Shanghai Tongji University

  Co-Author: Ignacio Briceño Balcázar, n/a – Universidad de La Sabana, Fibrodisplasia osificante progresiva en Colombia

  Co-Author: Erik Iván Quevedo Langenegger, n/a – Clínica Inmunomédica, Universidad de Concepción

  Co-Author: Kavitha Rethanavelu, n/a – Kuala Lumpur Hospital

  Co-Author: Toshifumi Fujiwara, MD – Kyushu University Hospital

  Co-Author: Kenichi Mishima, MD – Nagoya University Hospital

  Co-Author: Jacek Tabarkiewicz, n/a – Medical College of University of Rzeszów

  Co-Author: Thomas Funck-Brentano, n/a – Lariboisière Hospital AP-HP

  Co-Author: Raphaella Stander, n/a – University of Cape Town

  Co-Author: Javier Bachiller-Corral, n/a – Hospital Universitario Ramón y Cajal

  Co-Author: Kathryn M. Dahir, MD – Vanderbilt University Medical Center

  Co-Author: E. Marelise W. Eekhoff, n/a – Amsterdam University Medical Center

  Co-Author: Matti Hero, n/a – New Children’s Hospital, Helsinki University Hospital

  Co-Author: Evelyn Kuong, n/a – Queen Mary Hospital

  Co-Author: Naoto Uemura, MD, PhD – Oita University

  Co-Author: Meijian Zhou, n/a – Regeneron Pharmaceuticals, Inc.

  Co-Author: Dinko Gonzalez Trotter, n/a – Regeneron Pharmaceuticals, Inc.

  Co-Author: Jing Gu, Ph.D. – REGENERON PHARM INC

  Co-Author: Donal O’Donovan, n/a – Regeneron Pharmaceuticals, Inc.

  Co-Author: Robert Pordy, MD – Regeneron Pharmaceuticals, Inc.

  Co-Author: Boaz Hirshberg, n/a – Regeneron Pharmaceuticals, Inc.

  Co-Author: George D. Yancopoulos, n/a – Regeneron Pharmaceuticals, Inc.

  Oral Abstract Presenter: Richard Keen, MD PhD – Royal National Orthopaedic Hospital
• 10:15 AM - 10:30 AM CT

  Real-World Effectiveness of Burosumab in Adults with X-Linked Hypophosphatemia (XLH): An Item-Level Analysis of the Western Ontario and McMaster Universities Osteoarthritis Index
  

  Oral Abstract Presenter: Erik A. Imel, MD – Indiana University School of Medicine

  Co-Author: Steven W. Ing, MD (he/him/his) – The Ohio State University Wexner Medical Center and Arthur G. James Comprehensive Cancer Center

  Co-Author: Sasigarn Bowden, MD – Ohio State University Wexner Medical Center

  Co-Author: Kathryn M. Dahir, MD – Vanderbilt University Medical Center

  Co-Author: Pablo Florenzano, MD – Pontificia Universidad Católica de Chile

  Co-Author: Ingrid A. Holm, MD MPH – Harvard Medical School

  Co-Author: Sarah Khan, MD FRCPC – Bone Research and Education Clinic and Credit Valley Hospital

  Co-Author: Michael A. Levine, MD, ML, MACE (he/him/his) – The Children's Hospital of Philadelphia

  Co-Author: Carolina A. Moreira, MD, PhD – Federal University of Parana

  Co-Author: Laila Tabatabai, MD, CCD – Weill Cornell Medical College

  Co-Author: Thomas J. Weber, MD – Duke University Medical Center

  Co-Author: Shubham Tewari, MSc – KMK Consulting Inc

  Co-Author: Ben Johnson, MSc – Kyowa Kirin International plc

  Co-Author: Marc Vincent, DPT, MS – Kyowa Kirin Inc

  Co-Author: Lak N. Kotinkaduwa, PhD – Kyowa Kirin Inc

  Co-Author: Zhiyi Li, MBA, MA – Kyowa Kirin Inc

  Senior Author/Primary Investigator: Leanne M. Ward, MD, FRCPC – Children's Hospital of Eastern Ontario, University of Ottawa